高血压合并2型糖尿病患者血浆脂联素与血管内皮功能相关性研究(3)
 |
| 第1页 |
参见附件(3078KB，3页)。
[2]林君耀,曾丰年,郭木恭,等.氯沙坦对糖尿病合并原发性高血压患者内皮细胞功能的影响[J].中国心血管病研究,2009,7(5):351-353.
[3]Lara-Castro C, Fu Y, Chung BH, et al.Adiponectin and the metabolic syndrome:mechanisms mediating risk for metabolic and cardiovascular disease[J].Curt Opin Lipidol,2007,18(3):263-270.
[4]中国高血压防治指南修订委员会.中国高血压防治指南(2005年修订版)[J].高血压杂志,2005,13(1):S2-41.
[5]K.G. Alberti, P.Z. Zimmet.Definition diagnosis and classification of diabetes mellitus and its Complications. Part 1: diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation[J]. Diabet Med, 1998,15(7):539-553.
[6]Mallamaci F, Zoccali C, Cuzzola F, et al.Matsuzawa Y.Adiponectin in essential hypertensio[J].J Nephrol,2002,15(5):507- 511.
[7]Adamczak M, Wiecek A,Funahashi T,et al.Decreased plasma adiponectin concentrations in patients with essential hypertension[J].Am J Hypertens,2003,16(1):72-75.
[8]孟秋云,李秀昌,孙红,等.血清脂联素水平与高血压及心肌纤维化的关系[J].中国循环杂志,2010,25(2):111-113.
[9]Chow WS, Cheung BM, Tso AW,et al.Hypoadiponectinemia as a predictor for the development of hypertension:a 5-year prospective study[J].Hypertension,2007,49(6):1455-1461.
[10]徐莉,徐瑞金.缬沙坦改善原发性高血压患者血管内皮功能[J].中华高血压杂志,2006,14(8):624-626.
(收稿日期：2011-04-11)
注：本文中所涉及到的图表、注解、公式等内容请以PDF格式阅读原文
您现在查看是摘要介绍页，详见PDF附件(3078KB，3页)。